Results 151 to 160 of about 41,603 (297)

A Case of Laparoscopic Colon Fixation for Descending Colonic Volvulus Due to Persistent Descending Mesocolon

open access: yesThe Japanese Journal of Gastroenterological Surgery, 2022
Ryogo Ito   +7 more
openaire   +1 more source

Cellular neurilemoma (schwannoma) of the descending colon mimicking carcinoma: report of a case

open access: yes, 1998
We report a rare case of a cellular neurilemoma (schwannoma) of the descending colon, mimicking carcinoma, not accompanied by von Recklinghausen's disease.
Mylonakis, E. P.   +3 more
core  

Ophiopogonin D Mediates Therapeutic Effects on Primary Sjögren's Syndrome by Modulating Gut Microbiota and Metabolite Profiles

open access: yesBiomedical Chromatography, Volume 40, Issue 6, June 2026.
ABSTRACT This study aimed to investigate the mechanism of ophiopogonin D (OD) in treating primary Sjögren's syndrome (pSS) through integrated analysis of gut microbiota and metabolomics. Non‐obese diabetic/LtJ mice, a well‐established pSS model, were used as the model group and treated with OD or hydroxychloroquine.
Fengtao Pang   +3 more
wiley   +1 more source

Papillary Adenocarcinoma of the descending colon in a dog: case report

open access: yes
The aim of this report was to describe the clinical findings and therapeutic management of a case of papillary adenocarcinoma of the descending colon in a Beagle. The patient presented soft stools, haematochezia, tenesmus, and dyschezia.
J.O. Ribeiro   +12 more
core   +1 more source

Return of the Megaureter: A Sequel no One Expected an Enigmatic Case of Ureteral Stump Syndrome

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT This paper aims to emphasize the importance of not underestimating the potential complications of subtotal ureterectomy, despite their rarity. Ureteral Stump Syndrome can present with signs and symptoms that are not easily interpreted, and the range of differential diagnoses is broad and multidisciplinary.
Virginia Filippini   +4 more
wiley   +1 more source

Efficacy of Disitamab Vedotin in Treating HER2 2+/FISH‐Bladder Cancer: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 6, June 2026.
Timeline of treatment and sustained partial response in a patient with HER2 2+/FISH‐ bladder cancer (October 2019 – June 2024). ABSTRACT Disitamab Vedotin achieved durable partial response (> 8 months PFS) in advanced HER2 2+/FISH‐ bladder cancer after first‐line chemo‐immunotherapy progression.
Zhi‐ruo Jin   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy